Kathleen B.

Amherst, OH

Kathleen’s Testimonial for COPD Treatment

Age: 71  |  Location: Amherst, OH  |  Condition: COPD

As Kathleen B’s COPD and asthma progressively worsened, she had to quit doing her favorite activities and daily tasks. Her medications constantly changed, yet her condition continued to deteriorate. Frustrated by the lack of results and her diminishing energy, Kathleen and her husband investigated cellular therapy. She was skeptical at first, but after speaking with the Lung Institute team, she decided to give cellular therapy a try.

Before treatment, Kathleen couldn’t make her bed, cook dinner, take a shower or walk the few steps to her car without feeling exhausted and gasping for air. After treatment, Kathleen first noticed improvement when taking a shower became easier. Over time, her energy and activity levels continued to increase. Now, Kathleen and her husband can take trips together again, and she can do the things she couldn’t do before. “This is good. I feel normal,” Kathleen says.

If you or someone you love has COPD, emphysema, pulmonary fibrosis or another chronic lung disease and would like to see results like Kathleen’s, contact us at 888-745-6697 to learn more about your cellular treatment options.

Are you a candidate? Call 888-745-6697 to find out.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.